Official UK procurement notice
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
Authority: The NHS Commissioning Board (operating under the name of NHS England) (NHS & healthcare)
What is being bought4 lots · detail below
Published requirement descriptionCM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20/5591/02 - Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 monthsCM/PHR/20/5591/03 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021CM/PHR/20/5591/04 – Supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021
CPV: Pharmaceutical products
How this framework works
From the published notice- Bids received
- 30 bids received · 37 suppliers appointed
Lots and requirements (4)Procurement structure
4 lots · no lot values publishedLot #1Midlands and East (MAE) Tranche BCancelled
CM/PHR/20/5591/01 - NHS Framework for the Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lot #2Midlands and East Cytokine Modulators and other monoclonal antibodiesAwarded
CM/PHR/20/5591/02 - NHS Framework for the Midlands and East Branded Medicines – Annual Tranche, Cytokine Modulators, other monoclonal antibodies Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma. Period of framework: 1 March 2021 to 28 February 2022 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lot #3(LNW) – Interleukin Inhibitors, JAK Inhibitors, Migraine & AsthmaCancelled
CM/PHR/20/5591/03 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to Pan London. Period of framework: 1 March 2021 to 31 August 2021. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
Lot #4(SOFE) – Interleukin Inhibitors, JAK Inhibitors, Migraine & AsthmaCancelled
CM/PHR/20/5591/04 – NHS Framework agreement for the supply of Interleukin Inhibitors, JAK Inhibitors and medicines for Migraine and Asthma to South of England. Period of framework: 1 March 2021 to 31 August 2021. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
- “NHS Framework for the Midlands and East, Branded Medicines – Tranche B…” is a framework: the contest is a place on its panel, not a single contract.
Procedure terms & legal framework
From the official record- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 23 Feb 2021, 13:53 GMT
- Last source update
- 23 Feb 2021, 13:53 GMT
- Authority reference
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and- FTS notice number
2021/S 000-003581- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-029565Find a Tender
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast56 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 20 of these contracts carry the same published figure, £1, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Contract 003581-2021-1
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-10
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-11
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-12
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-13
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-14
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-15
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-16
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-17
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-18
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-19
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-2
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-20
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-21
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-22
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-23
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-24
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-25
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-26
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Contract 003581-2021-27
- Signed
- 25 Jan 2021
- Value
- ceiling above
- Status
- active
Bid statistics published by the authority
| Lot | Bids | SME | VCSE | Valid bid range |
|---|---|---|---|---|
| 2 · Midlands and East Cytokine Modulators and other monoclonal antibodies | 20bids | 3 | — | — |
| Whole notice | 30bids | 11 | — | — |
Contracting authority & participating public bodies
Framework contractors & participating bidders
37 commercial parties on the notice- Accord-UK LtdFramework contractor
- Amgen LtdFramework contractor
- AstraZenecaFramework contractor
- Aventis Pharma ltd t/a SanofiFramework contractor
- Bayer LtdFramework contractor
- BiogenFramework contractor
- Bristol Myers SquibbFramework contractor
- CST Pharma LimitedFramework contractor
- Celltrion Healthcare United Kingdom LimitedFramework contractor
- Daiichi Sankyo UK LtdFramework contractor
Show 27 more suppliers
- Day Lewis Medical LtdFramework contractor
- Dr.Reddy's Laboratories (UK) LimitedFramework contractor
- Eli Lilly and Company LtdFramework contractor
- Ferring Pharmaceuticals LtdFramework contractor
- Gedeon Richter UK LtdFramework contractor
- Gilead Sciences LimitedFramework contractor
- IpsenFramework contractor
- Janssen-Cilag LtdFramework contractor
- LEO PharmaFramework contractor
- Merck Serono LimitedFramework contractor
- Merck Sharp and Dohme (MSD)Framework contractor
- Merck Sharpe and Dohme (UK) LimitedFramework contractor
- MylanFramework contractor
- Napp Pharmaceuticals LtdFramework contractor
- Novartis Pharmaceuticals UK LtdFramework contractor
- Novo NordiskFramework contractor
- Pfizer LtdFramework contractor
- ROVI Biotech LtdFramework contractor
- Roche Products LtdFramework contractor
- Sandoz LtdFramework contractor
- Sobi (Swedish Orphan Biovitrum Ltd)Framework contractor
- Takeda UK LtdFramework contractor
- Techdow Pharma England LtdFramework contractor
- Teva UK LimitedFramework contractor
- Thornton and Ross LtdFramework contractor
- UCB Pharma LtdFramework contractor
- UL Global PharmaFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.